A fair growth of 13.78% in the revenue at Rs. 10782.50 millions was reported in the December 2019 quarter as compared to Rs. 9476.50 millions during year-ago period.The Profit  for the quarter ended December 2019 of  Rs. 1866.90  millions  grew by 59.50% from Rs. 1170.50 millions.Operating profit surged to 2674.60 millions from the corresponding previous quarter of 1841.20 millions. (Rs. in Million) Quarter ended Year to Date Year ended 201912 201812 % Var 201912 201812 % Var 201903 201803 % Var Sales 10782.50 9476.50 13.78 31319.40 27722.90 12.97 36786.00 33071.20 11.23 Other Income 277.60 376.30 -26.23 862.60 839.20 2.79 1132.90 1169.90 -3.16 PBIDT 2674.60 1841.20 45.26 7042.70 5357.70 31.45 7180.20 6414.90 11.93 Interest 18.60 4.30 332.56 57.10 15.10 278.15 22.50 38.20 -41.10 PBDT 2656.00 1836.90 44.59 6985.60 5342.60 30.75 7157.70 6376.70 12.25 Depreciation 150.50 39.60 280.05 448.00 120.10 273.02 169.20 161.90 4.51 PBT 2505.50 1797.30 39.40 6537.60 5222.50 25.18 6988.50 6214.80 12.45 TAX 638.60 626.80 1.88 1718.00 1851.20 -7.20 2485.20 2202.60 12.83 Deferred Tax -9.10 26.60 -134.21 2.70 0.50 440.00 26.40 -16.20 -262.96 PAT 1866.90 1170.50 59.50 4819.60 3371.30 42.96 4503.30 4012.20 12.24 Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00 PBIDTM(%) 24.81 19.43 27.67 22.49 19.33 16.36 19.52 19.40 0.63

The revenue zoomed 7.66% to Rs. 10548.00 millions for the quarter ended September 2019 as compared to Rs. 9797.20 millions during the corresponding quarter last year.The company has announced a 29.52% increase in its profits to Rs . 1783.30  millions for the  quarter ended September 2019 compared to Rs. 1376.80 millions in the corresponding quarter in the previous year.The company reported a good operating profit of 2330.30 millions compared to 2185.40 millions of corresponding previous quarter. (Rs. in Million) Quarter ended Year to Date Year ended 201909 201809 % Var 201909 201809 % Var 201903 201803 % Var Sales 10548.00 9797.20 7.66 20536.90 18246.40 12.55 36786.00 33071.20 11.23 Other Income 289.00 245.30 17.81 585.00 462.90 26.38 1132.90 1169.90 -3.16 PBIDT 2330.30 2185.40 6.63 4368.10 3516.50 24.22 7180.20 6414.90 11.93 Interest 18.20 5.20 250.00 38.50 10.80 256.48 22.50 38.20 -41.10 PBDT 2312.10 2180.20 6.05 4329.60 3505.70 23.50 7157.70 6376.70 12.25 Depreciation 149.50 40.60 268.23 297.50 80.50 269.57 169.20 161.90 4.51 PBT 2162.60 2139.60 1.07 4032.10 3425.20 17.72 6988.50 6214.80 12.45 TAX 379.30 762.80 -50.28 1079.40 1224.40 -11.84 2485.20 2202.60 12.83 Deferred Tax 19.70 -5.20 -478.85 11.80 -26.10 -145.21 26.40 -16.20 -262.96 PAT 1783.30 1376.80 29.52 2952.70 2200.80 34.16 4503.30 4012.20 12.24 Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00 PBIDTM(%) 22.09 22.31 -0.96 21.27 19.27 10.36 19.52 19.40 0.63

Abbott India is currently trading at Rs. 10620.00, up by 27.30 points or 0.26% from its previous closing of Rs. 10592.70 on the BSE.The scrip opened at Rs. 10544.80 and has touched a high and low of Rs. 10644.15 and Rs. 10350.00 respectively. So far 84 shares were traded on the counter.The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 11000.00 on 23-Sep-2019 and a 52 week low of Rs. 6900.00 on 26-Oct-2018.Last one week high and low of the scrip stood at Rs. 10995.35 and Rs. 10350.00 respectively. The current market cap of the company is Rs. 22511.51 crore.The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 9.21% and 15.80% respectively.Abbott in collaboration with TEDxGateway has hosted an interactive Salon session focused on the ‘Future of Healthcare’ - a platform dedicated to discuss how technology driven innovation is shaping the healthcare industry across the globe and in India.Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

A fair growth of 18.22% in the revenue at Rs. 9988.90 millions was reported in the June 2019 quarter as compared to Rs. 8449.20 millions during year-ago period.A good growth in profit of 41.92% reported to Rs. 1169.40  millions over Rs. 824.00 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 2037.80 millions from 1331.10 millions in the same quarter last year. (Rs. in Million) Quarter ended Year to Date Year ended 201906 201806 % Var 201906 201806 % Var 201903 201803 % Var Sales 9988.90 8449.20 18.22 9988.90 8449.20 18.22 36786.00 33071.20 11.23 Other Income 296.00 217.60 36.03 296.00 217.60 36.03 1132.90 1169.90 -3.16 PBIDT 2037.80 1331.10 53.09 2037.80 1331.10 53.09 7180.20 6414.90 11.93 Interest 20.30 5.60 262.50 20.30 5.60 262.50 22.50 38.20 -41.10 PBDT 2017.50 1325.50 52.21 2017.50 1325.50 52.21 7157.70 6376.70 12.25 Depreciation 148.00 39.90 270.93 148.00 39.90 270.93 169.20 161.90 4.51 PBT 1869.50 1285.60 45.42 1869.50 1285.60 45.42 6988.50 6214.80 12.45 TAX 700.10 461.60 51.67 700.10 461.60 51.67 2485.20 2202.60 12.83 Deferred Tax -7.90 -20.90 -62.20 -7.90 -20.90 -62.20 26.40 -16.20 -262.96 PAT 1169.40 824.00 41.92 1169.40 824.00 41.92 4503.30 4012.20 12.24 Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00 PBIDTM(%) 20.40 15.75 29.49 20.40 15.75 29.49 19.52 19.40 0.63

Abbott India is currently trading at Rs. 8613.00, up by 31.65 points or 0.37% from its previous closing of Rs. 8581.35 on the BSE.The scrip opened at Rs. 8614.35 and has touched a high and low of Rs. 8620.00 and Rs. 8610.30 respectively. The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 8834.05 on 10-Sep-2018 and a 52 week low of Rs. 6300.00 on 14-Jun-2018.Last one week high and low of the scrip stood at Rs. 8670.00 and Rs. 7930.00 respectively. The current market cap of the company is Rs. 18304.89 crore.The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 9.04% and 15.98% respectively.Abbott has unveiled sensor enabled HD grid mapping catheter, a device that can be inserted in the body to treat diseases or perform surgical procedures, in India.The company has launched the product after receiving clearance from the US Food and Drug Administration (USFDA) last year.Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

The company witnessed a 14.96% growth in the revenue at Rs. 9063.10 millions for the quarter ended March 2019 as compared to Rs. 7883.60 millions during the year-ago period.The Company has registered profit of Rs. 1131.90  millions for the quarter ended March 2019, a growth of 13.10%  over Rs. 1000.80 millions millions achieved in the corresponding quarter of last year.OP of the company witnessed a marginal growth to 1822.60 millions from 1652.20 millions in the same quarter last year. (Rs. in Million) Quarter ended Year to Date Year ended 201903 201803 % Var 201903 201803 % Var 201803 201703 % Var Sales 9063.10 7883.60 14.96 36786.00 33071.40 11.23 33071.20 29386.90 12.54 Other Income 293.60 586.00 -49.90 1132.80 1169.90 -3.17 1169.90 576.40 102.97 PBIDT 1822.60 1652.20 10.31 7180.30 6415.10 11.93 6414.90 4549.60 41.00 Interest 7.50 22.10 -66.06 22.60 38.20 -40.84 38.20 20.40 87.25 PBDT 1815.10 1630.10 11.35 7157.70 6376.90 12.24 6376.70 4529.20 40.79 Depreciation 49.10 39.60 23.99 169.20 161.90 4.51 161.90 164.30 -1.46 PBT 1766.00 1590.50 11.03 6988.50 6215.00 12.45 6214.80 4364.90 42.38 TAX 634.10 589.70 7.53 2485.30 2202.60 12.83 2202.60 1598.40 37.80 Deferred Tax 26.00 -3.10 -938.71 26.50 -16.20 -263.58 -16.20 -20.00 -19.00 PAT 1131.90 1000.80 13.10 4503.20 4012.40 12.23 4012.20 2766.50 45.03 Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00 PBIDTM(%) 20.11 20.96 -4.04 19.52 19.40 0.63 19.40 15.48 25.29

The revenue for the December 2018 quarter is pegged at Rs. 9476.50 millions, about 7.51% up against Rs. 8814.90 millions recorded during the year-ago period.Profit after tax improved marginally to Rs. 1170.50  millions for the quarter ended December 2018 from Rs. 1153.90 millions of corresponding previous quarter.Operating profit surged to 1841.20 millions from the corresponding previous quarter of 1823.40 millions. (Rs. in Million) Quarter ended Year to Date Year ended 201812 201712 % Var 201812 201712 % Var 201803 201703 % Var Sales 9476.50 8814.90 7.51 27722.90 25187.80 10.06 33071.20 29386.90 12.54 Other Income 376.30 190.00 98.05 839.20 583.90 43.72 1169.90 576.40 102.97 PBIDT 1841.20 1823.40 0.98 5357.70 4762.90 12.49 6414.90 4549.60 41.00 Interest 4.30 5.10 -15.69 15.10 16.10 -6.21 38.20 20.40 87.25 PBDT 1836.90 1818.30 1.02 5342.60 4746.80 12.55 6376.70 4529.20 40.79 Depreciation 39.60 42.20 -6.16 120.10 122.30 -1.80 161.90 164.30 -1.46 PBT 1797.30 1776.10 1.19 5222.50 4624.50 12.93 6214.80 4364.90 42.38 TAX 626.80 622.20 0.74 1851.20 1612.90 14.77 2202.60 1598.40 37.80 Deferred Tax 26.60 3.50 660.00 0.50 -13.10 -103.82 -16.20 -20.00 -19.00 PAT 1170.50 1153.90 1.44 3371.30 3011.60 11.94 4012.20 2766.50 45.03 Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00 PBIDTM(%) 19.43 20.69 -6.07 19.33 18.91 2.20 19.40 15.48 25.29

Abbott India is currently trading at Rs. 7750.00, up by 149.50 points or 1.97% from its previous closing of Rs. 7600.50 on the BSE.The scrip opened at Rs. 7630.00 and has touched a high and low of Rs. 7778.95 and Rs. 7630.00 respectively. So far 310 shares were traded on the counter.The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 8199.00 on 06-Aug-2018 and a 52 week low of Rs. 4035.00 on 18-Sep-2017.Last one week high and low of the scrip stood at Rs. 8010.00 and Rs. 7514.15 respectively. The current market cap of the company is Rs. 16457.58 crore.The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 9.30% and 15.72% respectively.Abbott India is eyeing to launch around 100 products over the next five years with an aim to strengthen existing therapy areas such as gastroenterology, metabolics, vaccines, central nervous system and women`s health. The company is also looking at strengthening its over-the-counter portfolio with a wider range of product formats. The company had launched 21 new products in the country during last fiscal year.Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott India is currently trading at Rs. 6725.65, up by 168.50 points or 2.57% from its previous closing of Rs. 6557.15 on the BSE.The scrip opened at Rs. 6600.00 and has touched a high and low of Rs. 7353.45 and Rs. 6400.00 respectively. So far 4868 shares were traded on the counter.The BSE group `B` stock of face value Rs. 10 has touched a 52 week high of Rs. 7353.45 on 15-May-2018 and a 52 week low of Rs. 3996.00 on 29-May-2017.Last one week high and low of the scrip stood at Rs. 7353.45 and Rs. 6200.00 respectively. The current market cap of the company is Rs. 14684.86 crore.The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 9.44% and 15.58% respectively.The company has reported over 2-fold jump in its net profit at Rs 100.08 crore for the quarter ended March 31, 2018 as compared to Rs 42.06 crore for the same quarter in the previous year. Total income of the company increased by 15.88% at Rs 846.96 crore for quarter under review as compared to Rs 730.87 crore for the quarter ended March 31, 2017.For the year ended March 31, 2018, the company has posted a rise of 45.03% in its net profit at Rs 401.22 crore as compared to Rs 276.65 crore for the previous year. Total income of company increased by 14.28% at Rs 3424.11 crore for year under review as compared to Rs 2996.33 crore for the year ended March 31, 2017.

The December 2017 quarter revenue stood at Rs. 8814.90 millions, up 16.64% as compared to Rs. 7557.20 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended December 2017 rise to 34.86% to Rs. 1153.90  millions  compared to R. 855.60 millions in corresponding previous quarter.The company reported a good operating profit of 1823.40 millions compared to 1369.60 millions of corresponding previous quarter. (Rs. in Million) Quarter ended Year to Date Year ended 201712 201612 % Var 201712 201612 % Var 201703 201603 % Var Sales 8814.90 7557.20 16.64 25272.00 22232.70 13.67 29386.90 26456.40 11.08 Other Income 190.00 139.00 36.69 499.70 421.90 18.44 576.40 505.90 13.94 PBIDT 1823.40 1369.60 33.13 4762.90 3766.40 26.46 4549.60 4149.70 9.64 Interest 5.10 0.10 5000.00 16.10 0.40 3925.00 20.40 25.20 -19.05 PBDT 1818.30 1369.50 32.77 4746.80 3766.00 26.04 4529.20 4124.50 9.81 Depreciation 42.20 43.50 -2.99 122.30 125.90 -2.86 164.30 144.40 13.78 PBT 1776.10 1326.00 33.94 4624.50 3640.10 27.04 4364.90 3980.10 9.67 TAX 622.20 470.40 32.27 1612.90 1294.20 24.63 1598.40 1427.60 11.96 Deferred Tax 3.50 -1.10 -418.18 -13.10 -6.90 89.86 -20.00 -13.80 44.93 PAT 1153.90 855.60 34.86 3011.60 2345.90 28.38 2766.50 2552.50 8.38 Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00 PBIDTM(%) 20.69 18.12 14.14 18.85 16.94 11.25 15.48 15.69 -1.30

The sales for the September 2017 quarter moved up 27.63% to Rs. 9309.80 millions as compared to Rs. 7294.30 millions during the corresponding quarter last year.Profit for the quarter ended September 2017 rises by 83.31% to Rs. 1375.20  millions from Rs. 750.20 millions.The company reported a good operating profit of 2164.00 millions compared to 1203.40 millions of corresponding previous quarter. (Rs. in Million) Quarter ended Year to Date Year ended 201709 201609 % Var 201709 201609 % Var 201703 201603 % Var Sales 9309.80 7294.30 27.63 16457.10 14675.50 12.14 29386.90 26456.40 11.08 Other Income 150.60 143.50 4.95 309.70 282.90 9.47 576.40 505.90 13.94 PBIDT 2164.00 1203.40 79.82 2939.50 2396.80 22.64 4549.60 4149.70 9.64 Interest 5.90 0.10 5800.00 11.00 0.30 3566.67 20.40 25.20 -19.05 PBDT 2158.10 1203.30 79.35 2928.50 2396.50 22.20 4529.20 4124.50 9.81 Depreciation 40.40 40.80 -0.98 80.10 82.40 -2.79 164.30 144.40 13.78 PBT 2117.70 1162.50 82.17 2848.40 2314.10 23.09 4364.90 3980.10 9.67 TAX 742.50 412.30 80.09 990.70 823.80 20.26 1598.40 1427.60 11.96 Deferred Tax -8.70 -3.50 148.57 -16.60 -5.80 186.21 -20.00 -13.80 44.93 PAT 1375.20 750.20 83.31 1857.70 1490.30 24.65 2766.50 2552.50 8.38 Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00 PBIDTM(%) 23.24 16.50 40.89 17.86 16.33 9.37 15.48 15.69 -1.30

A slight decline in the revenue of Rs. 7147.30 millions was seen for the June 2017 quarter as against Rs. 7381.20 millions during year-ago period.The Company to register a -34.81%  fall in the net profit for the quarter ended June 2017.Operating Profit reported a sharp decline to 775.50 millions from 1193.40 millions in the corresponding previous quarter. (Rs. in Million) Quarter ended Year to Date Year ended 201706 201606 % Var 201706 201606 % Var 201703 201603 % Var Sales 7147.30 7381.20 -3.17 7147.30 7381.20 -3.17 29386.90 26456.40 11.08 Other Income 159.10 139.40 14.13 159.10 139.40 14.13 576.40 505.90 13.94 PBIDT 775.50 1193.40 -35.02 775.50 1193.40 -35.02 4549.60 4149.70 9.64 Interest 5.10 0.20 2450.00 5.10 0.20 2450.00 20.40 25.20 -19.05 PBDT 770.40 1193.20 -35.43 770.40 1193.20 -35.43 4529.20 4124.50 9.81 Depreciation 39.70 41.60 -4.57 39.70 41.60 -4.57 164.30 144.40 13.78 PBT 730.70 1151.60 -36.55 730.70 1151.60 -36.55 4364.90 3980.10 9.67 TAX 248.20 411.50 -39.68 248.20 411.50 -39.68 1598.40 1427.60 11.96 Deferred Tax -7.90 -2.30 243.48 -7.90 -2.30 243.48 -20.00 -13.80 44.93 PAT 482.50 740.10 -34.81 482.50 740.10 -34.81 2766.50 2552.50 8.38 Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00 PBIDTM(%) 10.85 16.17 -32.89 10.85 16.17 -32.89 15.48 15.69 -1.30